Friday, April 17, 2026

Advertise With Us
Sign In


Home Business Life Sciences and Bio Pharma Fudan Team Develops HG-TCs Met...

Fudan Team Develops HG-TCs Method for Glycoproteomics Advancements


Life Sciences and Bio Pharma

Fudan, Glycosylation, Chemical Ligation

 Fudan University researchers develop HG-TCs method to enhance glycosylation analysis in glycoproteomics.

A team of researchers from Fudan University has developed a new strategy for glycopeptide enrichment using chemical ligation, a method that could revolutionize the study of protein glycosylation. Now, the newly published procedure, HG-TCs, is named after "chemical ligation-based glycopeptide enrichment". To identify N-glycosites, O-GlcNAc sites, as well as O-GalNAc sites and N-glycans, using advance materials about the solidity phase and the principles from the science of bioorthogonal chemistry comes through, writes M. Sajid Qadeer.

Protein glycosylation plays an important role in the cellular functions and disease mechanisms. However, the complexity and low abundance of glycoproteins have made their study difficult. The strategy for HG-TCs overcomes these challenges using an azide-alkyne cycloaddition reaction to enrich glycopeptides released by trypsin cleavage. In this one-tube workflow, there is minimal loss in samples, ensuring a high reproducibility and efficiency in sample processing.

The method also affords remarkable scalability, enabling identification of more than 900 O-GlcNAc sites and 800 N-glycosites from HeLa cells in one experiment, with minimal sample input. Furthermore, the technique can map multiple glycosylations simultaneously and monitor changes at these sites, especially in dynamic biological environments.

This group of researchers applied HG-TCs to the HeLa cell samples treated with oxidative stress conditions; they found distinct spatial glycosylation patterns between the nucleus and cytoplasm, which opens new avenues toward understanding the role of glycosylation in cellular stress responses.

This new approach opens an important avenue for glycosylation studies in cancer and other diseases, streamlining complex workflows but maintaining high data quality. The HG-TCs strategy is expected to profoundly advance glycoproteomics and facilitate better understanding of the dynamic roles of glycosylation in cellular signaling and disease mechanisms.


Business News


Recommended News

×

Subscribe To Our Newsletter

email

please enter valid email

×
tankyu


Latest Magazine